Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Adv Therapy

Search In Journal Title:

Abbravation: Advances in Therapy

Search In Journal Abbravation:

Publisher

Springer Healthcare Communications

Search In Publisher:

DOI

10.1002/9781118061992.ch24

Search In DOI:

ISSN

1865-8652

Search In ISSN:
Search In Title Of Papers:

The pharmacodynamic properties of azithromycin in

Authors: Mark S Dorfman Rudolph S Wagner Tiffany Jamison Belinda Bell David W Stroman
Publish Date: 2008/03/27
Volume: 25, Issue: 3, Pages: 208-217
PDF Link

Abstract

Antibiotics have traditionally been classified as bactericidal or bacteriostatic Azithromycin belongs to the parent class of macrolides that are characteristically bacteriostatic Some evidence suggests that this molecule demonstrates bactericidal kill and has concentrationdependent effects This study tests the hypothesis that azithromycin demonstrates a bactericidal concentrationdependent antibiotic effect at concentrations corresponding to and exceeding published tear and conjunctival levelsThe antibacterial activity of different concentrations of azithromycin 1 in DuraSite® AzaSite® Inspire Pharmaceuticals Inc Durham NC USA was evaluated using a kineticsofkill model Recent conjunctivitis isolates of Staphylococcus aureus Streptococcus pneumoniae or Haemophilus influenzae were exposed to four concentrations of azithromycin 100 250 500 and 750 μg/ml Starting concentrations were similar to the maximum concentrations Cmax that have been demonstrated in conjunctiva 83 μg/g and tears 288 μg/ml following topical ocular administration The percentage of surviving bacteria at 30 and 60 minutes following exposure to each concentration were determinedAzithromycin failed to demonstrate bactericidal activity ie a 3log reduction in surviving bacteria against S aureus S pneumoniae or H influenzae Furthermore the rate and extent of antibacterial activity with azithromycin did not change with higher concentrations even at the highest tested concentration of 750 μg/mlSimilar to the parent macrolide class azithromycin demonstrates bacteriostatic activity against common conjunctival pathogens up to the maximum tested concentration of 750 μg/ml ie 26times and 9times published Cmax tear and conjunctival concentration respectively Azithromycin’s bacteriostatic effects and prolonged elimination halflife will likely lead to a corresponding increase in the emergence of macrolideresistant isolates


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Azacytidine for the treatment of myelodysplastic syndromes in the elderly
  2. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  3. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  4. When People with Opioid-Induced Constipation Speak: A Patient Survey
  5. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
  6. Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
  7. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
  8. A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  9. Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  10. Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy
  11. Coma caused by isoniazid poisoning in a patient treated with pyridoxine and hemodialysis
  12. Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?
  13. An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
  14. Slovak Trial on Cardiovascular Risk Reduction Following National Guidelines with CaDUET® (The STRONG DUET Study)
  15. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
  16. Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops
  17. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
  18. Advances in Clinical Cardiology
  19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
  20. Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β 1 -Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
  21. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals
  22. Glial fibrillary acidic protein (GFAP) and CD34 expression in the human optic nerve and brain in methanol toxicity
  23. Urapidil, a dual-acting antihypertensive agent: Current usage considerations

Search Result: